Back to search
Pantothenate Kinase-associated Neurodegeneration (PKAN)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pantothenate Kinase-associated Neurodegeneration (PKAN) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pantothenate Kinase-associated Neurodegeneration (PKAN) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
TIRCON-reg aims to * continue the provision of a global registry and natural history study for NBIA disorders * harmonize and cover existing national and singl…
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed…
The purpose of this study is to learn more about how people with the condition pantothenate kinase-associated neurodegeneration (PKAN) respond to a specialized…
Rares diseases are a heterogeneous group of conditions which need important tools for diagnosis. The use of high-throughput sequencing is able to diagnose half…